AMGN vs INCY
By Alex · Tickerpine
Amgen Inc. vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | INCY |
|---|---|---|
| Price | $416.18 | $120.77 |
| Market cap | $225.15B | $24.48B |
| P/E ratio | 25.7 | 15.4 |
| ROE | 91.47% | 30.67% |
| Profit margin | 22.95% | 27.71% |
| Revenue growth | 9.50% | 37.70% |
| Dividend yield | 2.43% | — |
| Beta | 0.41 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs INCY in plain English
- AMGN is the bigger company — about 9.2× the market cap of INCY.
- INCY is cheaper on earnings (P/E 15.4 vs 25.7).
- AMGN earns a higher return on equity (91% vs 31%).
- INCY is growing revenue faster (38% vs 10%).
- AMGN pays a dividend (2.43%) while the other effectively doesn't.
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.